<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - NASDAQ Biotechnology</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sun, 26 Apr 2026 02:31:29 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>FDA Zulassungstermine</title>
<link>http://www.aktiencheck.de/forum/FDA_Zulassungstermine-617026-t538598</link>
<guid>http://www.aktiencheck.de/forum/FDA_Zulassungstermine-617026-t538598</guid>
<description>@Insider86 Dieses Wissen, hätte ich jetzt von einem Insider erwartet ;-) [&lt;a href=&#034;http://www.aktiencheck.de/forum/FDA_Zulassungstermine-617026-t538598&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>Auxilium Pharmaceuticals</title>
<link>http://www.aktiencheck.de/forum/Auxilium_Pharmaceuticals-617026-t503230</link>
<guid>http://www.aktiencheck.de/forum/Auxilium_Pharmaceuticals-617026-t503230</guid>
<description>Endo To Acquire Auxilium, - Auxilium Shareholders to Receive $33.25 Per Share

- Combination Designed to Create Leading Specialty Healthcare Company with Expanded Platform for Future Growth

- Addition of Auxilium's Leading Men's Health Products and Development Portfolio Expected to Significantly Enhance Endo's Branded Pharmaceutical Business

- Transaction Expected to be Immediately Accretive

- Endo Expects to Generate up to $175 Million of Annual Run Rate Operating Expense Reductions Inclusive of the $75 Million of Reductions Previously Announced by AuxiliumEndo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 BillionAUXL Auxilium Pharmaceuticals, Inc. (MM) Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billionhttp://ih.advfn.com/p. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Auxilium_Pharmaceuticals-617026-t503230&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







